| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/22/2010 | US20100184958 for treating diseases related to HB-EGF escalation; such as heart diseases, arteriosclerosis, cancer |
| 07/22/2010 | US20100184957 Porous base matrix having formyl group, adsorbent using the porous base matrix, method for production of the porous base matrix, and method for production of the adsorbent |
| 07/22/2010 | US20100184951 Truncated BAFF Receptors |
| 07/22/2010 | US20100184843 Identification of a pin specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer |
| 07/22/2010 | US20100184842 Ultraconserved Regions Encoding ncRNAs |
| 07/22/2010 | US20100184697 Peptide-based stat inhibitor |
| 07/22/2010 | US20100184686 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/22/2010 | US20100184684 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184683 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184681 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184671 Binding molecules for the treatment of myeloid cell malignancies |
| 07/22/2010 | US20100184660 Single exon genes encoding for novel bio-active peptides |
| 07/22/2010 | US20100184657 Methods of treating epithelial lesions outside the stomach and intestines |
| 07/22/2010 | US20100184654 Anti-microbial targeting chimeric pharmaceutical |
| 07/22/2010 | US20100184639 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains |
| 07/22/2010 | US20100184184 Production of Conjugates |
| 07/22/2010 | US20100184105 Assessing neuronal damage from blood samples |
| 07/22/2010 | US20100184091 Method for determining MIF content |
| 07/22/2010 | US20100184088 Methods of identifying agents that modulate methylation of vegfr1 by smyd3 |
| 07/22/2010 | US20100184085 Prokaryotic collage-like proteins and uses thereof |
| 07/22/2010 | US20100184082 Antibody and immunoassays for determining the presence of delta9-tetrahydrocannabinol |
| 07/22/2010 | US20100184021 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis |
| 07/22/2010 | US20100184016 Methods and compositions in the treatment of porcine circoviral infection |
| 07/22/2010 | US20100184014 Non-M, non-O HIV-1 strains, fragments and uses |
| 07/22/2010 | US20100183674 immunization; comprised of a fusion protein; bioterrorism; plague |
| 07/22/2010 | US20100183654 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 07/22/2010 | US20100183653 Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof |
| 07/22/2010 | US20100183645 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 07/22/2010 | US20100183636 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 07/22/2010 | US20100183635 Glycosylated specificity exchangers |
| 07/22/2010 | US20100183634 Multifunctional nucleic acid nano-structures |
| 07/22/2010 | US20100183633 Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition |
| 07/22/2010 | US20100183632 Antibody Therapy For Modulating Function Of Intestinal Receptors |
| 07/22/2010 | US20100183631 Antibodies Directed to HER-3 and Uses Thereof |
| 07/22/2010 | US20100183630 Tat-005 and Methods of Assessing and Treating Cancer |
| 07/22/2010 | US20100183627 Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
| 07/22/2010 | US20100183623 Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
| 07/22/2010 | US20100183621 Fully human antibodies against human 4-1BB |
| 07/22/2010 | US20100183619 Neutralizing Antibodies and Methods of Use Thereof |
| 07/22/2010 | US20100183618 Anti-epha2 antibody |
| 07/22/2010 | US20100183617 Compositions and methods for regulating sas1r |
| 07/22/2010 | US20100183616 Antibodies against interleukin-1 beta |
| 07/22/2010 | US20100183615 Cross-species-specific bispecific binders |
| 07/22/2010 | US20100183614 Immunoglobulins directed to bacterial, viral and endogeneous polypeptides |
| 07/22/2010 | US20100183611 Targeted cryptosporidium biocides |
| 07/22/2010 | US20100183610 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183608 Drg11-responsive (dragon) gene and uses thereof |
| 07/22/2010 | US20100183607 Risk markers for cardiovascular disease |
| 07/22/2010 | US20100183602 Induction of Tolerogenic Phenotype in Mature Dendritic Cells |
| 07/22/2010 | US20100183599 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/22/2010 | US20100183596 Virulence Factors of Streptoccus Pnuemoniae |
| 07/22/2010 | US20100183595 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 07/22/2010 | US20100183590 LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 07/22/2010 | US20100183589 Human blood proteins expressed in monocot seeds |
| 07/22/2010 | US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines |
| 07/22/2010 | US20100183584 Conformation and activity of gbeta5 complexes |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183578 Nitroprotein biomarkers for copd |
| 07/22/2010 | US20100183562 Sub -population of hematopoietic stem cells that express the crisp-1 protein |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/22/2010 | US20100183554 Anti-CD3 Antibodies and Methods of Use Thereof |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183544 Method of treatment |
| 07/22/2010 | US20100183541 Methods of Treating Autoimmune Diseases |
| 07/22/2010 | US20100183512 Use of cthrc1 in diagnosing cancer of liver |
| 07/22/2010 | US20100183505 Immunoconjugate for human cd66 for the treatment of multiple myeloma and other haematological malignancies |
| 07/22/2010 | CA2749627A1 Recombinant monovalent antibodies |
| 07/22/2010 | CA2749572A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins |
| 07/22/2010 | CA2748809A1 Precipitation of biomolecules with negatively charged polymers |
| 07/22/2010 | CA2748758A1 Antibodies against human epo receptor |
| 07/22/2010 | CA2746964A1 Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| 07/21/2010 | EP2208793A1 Protein providing inducible resistance to glycopeptides, in particular in gram-positive bacteria |
| 07/21/2010 | EP2208784A1 Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2207882A1 Cho-k1 cell line |
| 07/21/2010 | EP2207881A1 Protein expression from multiple nucleic acids |
| 07/21/2010 | EP2207879A2 Identification and isolation of fetal cells and nucleic acid |
| 07/21/2010 | EP2207809A1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 07/21/2010 | EP2207808A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
| 07/21/2010 | EP2207807A2 Molecules and methods for modulating complement component |
| 07/21/2010 | EP2207806A1 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals |
| 07/21/2010 | EP2207804A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 07/21/2010 | EP2207803A1 Cd9-specific human antibodies |
| 07/21/2010 | EP2207797A1 Modulation of sirpalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 07/21/2010 | EP2207794A1 Compositions and methods for making androstenediones |
| 07/21/2010 | EP2207568A2 Antibodies specific for the protofibril form of beta-amyloid protein |
| 07/21/2010 | EP2207565A2 Immunotherapy regimes dependent on apoe status |
| 07/21/2010 | EP1812476B1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 07/21/2010 | EP1727901B1 Materials and methods for treatment of cancer |
| 07/21/2010 | EP1684805B1 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma |
| 07/21/2010 | EP1682177B1 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 07/21/2010 | EP1276896B1 Epitope synchronization in antigen presenting cells |
| 07/21/2010 | EP1265928B1 Ultra high affinity rsv neutralizing antibodies |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1685039B Secreted acid phosphatase (SAPM) is present only in pathogenic mycobacteria and expressed selectively at phagosomal PH |
| 07/21/2010 | CN101784566A Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 07/21/2010 | CN101784565A conjugates containing hydrophilic spacer linkers |
| 07/21/2010 | CN101782579A Enzyme-linked immunoassay kit for detecting tiamulin medicaments, and application thereof |
| 07/21/2010 | CN101781656A Expression of odontoglossum ringspot virus (ORSV) coat protein gene and preparation method of antibody |